US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

55.64

-0.0600-0.11%

Post-market: 55.640.00000.00%16:15 EDT

Volume:7K

Turnover:378.51K

Market Cap:190.29M

PE:- -

High:55.81

Open:55.58

Low:55.48

Close:55.70

52wk High:56.45

52wk Low:39.08

Shares:3.42M

Float Shares:3.42M

Volume Ratio:0.33

T/O Rate:0.20%

Dividend:0.00

Dividend Rate:0.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Fresenius announces FDA approval of rituximab biosimilar

ClearPoint Neuro Q2 Revenue Rises 18% but Misses Estimates

GeneDx Q2 Revenue Beats Analyst Estimates

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Krystal Biotech Down Nearly 12%, on Pace for Largest Percent Decrease Since August 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks

Wall Street Analysts Are Bullish on Top Healthcare Picks

Krystal Biotech Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Design Therapeutics Q2 Net Loss Narrower than Expected

Ocular Therapeutix Q2 Product Revenue Flat, Net Loss Widens on Higher Spending

Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80

THOMSON REUTERS

Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength

Krystal Biotech Shares Down 5.8% Premarket After Q2 Results

THOMSON REUTERS

Krystal Biotech Q2 Net Income Rises 43% to $54.8 Million; Revenue Climbs 24% to $119.2 Million

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

THOMSON REUTERS

Krystal Biotech - Sees FY 2026 Non-Gaap R&D and SG&a Expense $175 Mln-$195 Mln

THOMSON REUTERS

Krystal Biotech Q2 Product Revenue USD 119.222 Million

THOMSON REUTERS

BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG

3 High Growth Stocks Investors May Be Missing Right Now

Simply Wall St.

Coursera Stock And 2 More Growth Picks Backed By Healthy Balance Sheets

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/PSCH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":55.64,"timestamp":1787774400000,"preClose":55.7,"halted":0,"volume":6799,"hourTrading":{"tag":"盘后","latestPrice":55.64,"preClose":55.64,"latestTime":"16:15 EDT","volume":11,"amount":612.04,"timestamp":1787775300270,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.001077199281867186,"floatShares":3420000,"shares":3420000,"eps":0,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"08-26 18:58:26 EDT","open":55.58,"high":55.81,"low":55.4825,"amount":378512,"amplitude":0.00588,"askPrice":58.56,"askSize":90,"bidPrice":53.25,"bidSize":90,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":55.7,"sharesOutstanding":3220000,"nav":55.44727,"aum":189075190.7,"dividendRate":0.000054,"bidAskSpread":0.001784,"preHourTrading":{"tag":"盘前","latestPrice":54.57,"preClose":55.7,"latestTime":"07:00 EDT","volume":53,"amount":2892.21,"timestamp":1787742014879,"change":-1.13,"changeRate":-0.020287,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":55.64,"preClose":55.64,"latestTime":"16:15 EDT","volume":11,"amount":612.04,"timestamp":1787775300270,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.329374,"impliedVol":0.1092,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3420000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.329374,"shares":3420000,"dividePrice":0.003,"high":55.81,"amplitude":0.00588,"preClose":55.7,"low":55.4825,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":55.64,"eps":0,"divideRate":0.000054,"volume":6799,"delay":0,"ttmEps":0,"open":55.58,"prevYearClose":44.0553,"prevWeekClose":55.6522,"prevMonthClose":53.39,"prevQuarterClose":52.3666,"fiveDayClose":56.22,"twentyDayClose":53.2244,"sixtyDayClose":44.8324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656304376","title":"Fresenius announces FDA approval of rituximab biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304376?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:15","pubTimestamp":1785788150,"startTime":"0","endTime":"0","summary":"Fresenius Kabi, an operating company of Fresenius (FSNUY), announced that the U.S. Food and Drug Administration has approved a rituximab biosimilar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fresenius-announces-fda-approval-of-rituximab-biosimilar-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","FSNUY","BK4196","PINK","LABU","FRTY","GDOC","SYNB","MRNY","BK4585","MEDI","BK4588","GNMX","IEIH","RSPH","NVIB","LFSC","IBB","IDNA","BBP","BMED","TBXU","XLVX","IYH","PSCH","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656083301","title":"ClearPoint Neuro Q2 Revenue Rises 18% but Misses Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2656083301","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656083301?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:14","pubTimestamp":1785788065,"startTime":"0","endTime":"0","summary":"ClearPoint Neuro Q2 revenue rises 18% but misses estimatesOverviewDevice and gene therapy-enabling firm's Q2 revenue rose 18% yr/yr but missed analyst expectationsGross margin improved to 62% from 60%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400ZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","CLPT","HELX","PSCH","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656301205","title":"GeneDx Q2 Revenue Beats Analyst Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301205?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:12","pubTimestamp":1785787943,"startTime":"0","endTime":"0","summary":"GeneDx Q2 revenue beats analyst estimatesOverviewU.S. rare disease genomics tester's Q2 revenue grew 11% yr/yr, beating analyst expectationsAdjusted net income was $0.4 mln, up from a loss in the prio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","KRYS","BK4196","HELX","BK4139","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656019363","title":"Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2656019363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656019363?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:09","pubTimestamp":1785787780,"startTime":"0","endTime":"0","summary":"Alkermes amends 8-K to disclose CEO Blair Jackson pay package including $5 million equity awardAlkermes amended a Feb. 25 Form 8-K on its CEO succession to add previously undetermined compensation ter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL2dlwWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","IBRN","MEDX","ALKS","FBT","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656303023","title":"Krystal Biotech Down Nearly 12%, on Pace for Largest Percent Decrease Since August 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2656303023","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656303023?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:25","pubTimestamp":1785777900,"startTime":"0","endTime":"0","summary":"Krystal Biotech, Inc.  is currently at $300.76, down $40.37 or 11.83%--Would be lowest close since June 2, 2026, when it closed at $293.21--On pace for largest percent decrease since Aug. 4, 2025, when it fell 14.04%--Currently down three of the past four days--Currently down two consecutive days; down 18.02% over this period--Worst two day stretch since the two days ending May 9, 2022, when it fell 21.35%--Up 21.99% year-to-date--Down 20.47% from its all-time closing high of $378.15 on June 29, 2026--Up 122.88% from 52 weeks ago , when it closed at $134.94--Down 20.47% from its 52-week closing high of $378.15 on June 29, 2026--Up 122.88% from its 52-week closing low of $134.94 on Aug. 4, 2025--Traded as low as $297.02; lowest intraday level since June 3, 2026, when it hit $290.04--Down 12.93% at today's intraday low; largest intraday percent decrease since Aug. 4, 2025, when it fell as much as 16.87%All data as of 1:20:00 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","HELX","PSCH","XBI","BK4581","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656330819","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656330819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656330819?lang=en_us&edition=fundamental","pubTime":"2026-08-04 00:00","pubTimestamp":1785772852,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opus Genetics (IRD) and Krystal Biotech (KRYS) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-271?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-271?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BK4139","KRYS","BK4007","IRD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656648372","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656648372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656648372?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:50","pubTimestamp":1785765023,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BrightSpring Health Services, Inc. (BTSG), Monte Ros...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","PTH","LU2089984988.USD","PSCH","BTSG","LU2324357040.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656374922","title":"Krystal Biotech Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656374922","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656374922?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:31","pubTimestamp":1785763905,"startTime":"0","endTime":"0","summary":"Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings SummaryKrystal Biotech IncKRYS.OQreported quarterly adjusted earnings of $1.79 per share for the quarter ended June 30, hig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4401GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","HELX","BK4139","KRYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656866379","title":"Design Therapeutics Q2 Net Loss Narrower than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2656866379","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656866379?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:15","pubTimestamp":1785759346,"startTime":"0","endTime":"0","summary":"Design Therapeutics Q2 net loss narrower than expectedOverviewUS biotech firm's Q2 net loss was lower than analyst expectationsOperating expenses for Q2 totaled $22.2 mlnCompany ended Q2 with $207.4 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL","BK4539","BK4588","TGTX","DSGN","PSCH","BK4585","HELX","KRYS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375311","title":"Ocular Therapeutix Q2 Product Revenue Flat, Net Loss Widens on Higher Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375311","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375311?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:21","pubTimestamp":1785756090,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Q2 product revenue flat, net loss widens on higher spendingOverviewUS biopharmaceutical firm's Q2 product revenue was flat yr/yrNet loss for Q2 widened compared to prior yearCompany","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400DI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4588","BK4501","KRYS","BK4533","BK4534","HELX","PSCH","GNOM","IDNA","MRNX","BK4139","BK4007","OCUL","BK4551","MRNY","WDNA","BK4532","BK4585","TGTX","MRNA","BK4548","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737143","title":"Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656737143?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:13","pubTimestamp":1785755617,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44016O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU2089984988.USD","BK4196","PTH","PSCH","LU2324357040.USD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373795","title":"Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373795","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373795?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:12","pubTimestamp":1785755552,"startTime":"0","endTime":"0","summary":"Krystal Biotech Q2 revenue rises on VYJUVEK strengthOverviewUS genetic medicines developer's Q2 product revenue grew 24% yr/yr to $119.2 mlnAdjusted EPS for Q2 rose to $1.79 from $1.29 a year agoCompa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU1923622614.USD","LU2237443465.HKD","PSCH","GLAM","IXJ","LU0456855351.SGD","KRYS","FTXH","IE00BLSP4239.USD","VHT","LU0234572021.USD","LU0859254822.USD","WDNA","RXL","LU0511384066.AUD","LU0320765646.SGD","PJP","IE0002270589.USD","LGHT","LU1061106388.HKD","MRNX","IE00BVYPNW00.USD","LU2237443622.USD","LU1732799900.SGD","LU2357627491.SGD","IE00BGHQF631.EUR","PPH","LU0553294199.USD","TRUH","MRNY","LU1934455863.HKD","HELX","AGNG","GNOM","IE00BJT1NW94.SGD","LU2089283258.USD","MRNA","XLV","JDOC","MEDX","FHLC","ABBV","IYH","LU1244550221.USD","LU2089284900.SGD","LU2129689514.USD","IE00B19Z3B42.SGD","BK4581","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656732883","title":"Krystal Biotech Shares Down 5.8% Premarket After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2656732883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656732883?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:08","pubTimestamp":1785755312,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","KRYS","HELX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373454","title":"Krystal Biotech Q2 Net Income Rises 43% to $54.8 Million; Revenue Climbs 24% to $119.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373454","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373454?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:05","pubTimestamp":1785755120,"startTime":"0","endTime":"0","summary":"Krystal Biotech Q2 net income rises 43% to $54.8 million; revenue climbs 24% to $119.2 millionKrystal Biotech posted 2Q net income of $54.8 million, or $1.79 per diluted share, up from $38.3 million a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL68yNBG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","KRYS","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","PSCH","HELX","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4112","SG9999014005.SGD","BCDF","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656437355","title":"Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2656437355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656437355?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA9HCNB6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","BK4139","HELX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656437394","title":"Krystal Biotech - Sees FY 2026 Non-Gaap R&D and SG&a Expense $175 Mln-$195 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2656437394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656437394?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXZ8VXL2:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HELX","KRYS","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656237352","title":"Krystal Biotech Q2 Product Revenue USD 119.222 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656237352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656237352?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXZ8VXL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656322698","title":"BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2656322698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656322698?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:11","pubTimestamp":1785748260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTSG","PTH","LU2324357040.USD","PSCH","LU2089984988.USD","LU2468319806.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656430313","title":"3 High Growth Stocks Investors May Be Missing Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2656430313","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656430313?lang=en_us&edition=fundamental","pubTime":"2026-08-03 03:22","pubTimestamp":1785698528,"startTime":"0","endTime":"0","summary":"Global markets are wrestling with higher energy prices, sticky inflation and shifting rate expectations across the US, UK and Eurozone. In this kind of backdrop, investors often look for companies that can grow earnings even when the macro story feels messy. The Healthy high growth potential screener focuses on stocks that analysts expect to deliver strong earnings growth over the next 3 years and that also sit in an acceptable financial position. This article highlights 3 of the best stocks...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/3-high-growth-stocks-investors-may-be-missing-right-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/3-high-growth-stocks-investors-may-be-missing-right-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSCH","LU1559883803.SGD","RGLO","BK4007","BK4211","VGFPF","JOYT","DECU","ALHC","VOTE","FEBU","CORT","FBT","BK4592","BK4532","BK4539","LU0566484027.USD","BK4204","GXDW","COUR","BK4154","PMDE","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656127323","title":"Coursera Stock And 2 More Growth Picks Backed By Healthy Balance Sheets","url":"https://stock-news.laohu8.com/highlight/detail?id=2656127323","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656127323?lang=en_us&edition=fundamental","pubTime":"2026-08-02 15:22","pubTimestamp":1785655346,"startTime":"0","endTime":"0","summary":"Global markets feel pulled between firm inflation, shifting central bank signals and uneven growth data. Bond yields in the US, UK and Europe keep pressure on valuations, while export powerhouses like South Korea highlight how specific growth stories can still stand out. In this mix, many investors seek companies where analysts see healthy earnings growth potential and balance sheets that look resilient. That is what the Healthy high growth potential screener targets. In this article, you...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/coursera-stock-and-2-more-growth-picks-backed-by-healthy-bal","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/coursera-stock-and-2-more-growth-picks-backed-by-healthy-bal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","COUR","FBT","ALHC","BK4204","LU1559883803.SGD","BK4532","BK4007","CORT","PMDE","LU0566484027.USD","BK4154","PSCH","BK4592","BK4539","VOTE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}